{
    "nctId": "NCT00263185",
    "briefTitle": "High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status",
    "officialTitle": "A Double-Blind, Randomized, Placebo Controlled Trial of High Dose Vitamin D Therapy On Musculoskeletal Symptoms and Bone Mineral Density in Anastrozole-Treated Early Stage Breast Cancer Patients With Marginal Vitamin D Status",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 63,
    "primaryOutcomeMeasure": "To compare the effects of high dose vitamin D versus standard dose vitamin D on musculoskeletal pain in breast cancer patients receiving anastrozole when vitamin D levels are in the insufficient but not deficient range (10 to 29 ng/ml).",
    "eligibilityCriteria": "Inclusion Criteria\n\n* Women with a diagnosis of hormone receptor positive invasive breast cancer (Stage I-IIIB) or ductal carcinoma in situ (DCIS)\n* Postmenopausal status\n* Completed at least 8 weeks of anastrozole as adjuvant therapy prior to study entry\n* Completed systemic chemotherapy and radiation treatments when indicated\n* Serum Calcium \u2264 10.3 mg/dL\n* Patients with marginal 25 OH Vitamin D level (between 10 and 29 ng/ml) will be in the Randomized Group or Low 25 OH Vitamin D level (less than 10 ng/ml) will be in Observational Group\n* 24-hour urine Calcium excretion \u2264 250 mg/g (calculated by dividing 24 hour calcium by 24 hour creatinine)\n* A history of generalized musculoskeletal pain with or without localized regions or discomfort that has developed or worsened since starting adjuvant aromatase inhibitor therapy\n\nExclusion Criteria\n\n* Known metastatic disease\n* History of kidney stones\n* History of active primary hyperparathyroidism\n* History of Paget's disease of the bone\n* History of severe arthritis, rheumatoid arthritis, or severe neuropathy\n* Normal 25 OH Vitamin D level (\u2265 30 ng/ml)\n* Medical or psychiatric condition which may preclude protocol compliance",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}